Log In
Print this Print this

Oral dry powder Viread, tenofovir disoproxil fumarate (EUR-1030)

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionOral powder formulation of Viread, a nucleotide analog prodrug reverse transcriptase inhibitor, that uses Aptalis Microcaps taste-masking technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV-1 infection in patients age 2-5 years
Regulatory Designation
PartnerGilead Sciences Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today